RMSGW Real CEO shares optimistic strategic growth roadmap following release of its latest quarterly earnings PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower PECO Phillips Q1 2026 earnings vastly outperform analyst forecasts shares rise modestly after results